Moreover, S100A9 released into the TME by monocytes and myeloid-derived suppressor cells can affect the carbohydrate and lipid metabolism and induce abnormal oxidative metabolism by the activation of NADPH oxidase of both tumor cells and their surrounding cells [93,94]. The gene discussed is FMO5; the disease is neoplasm.